What should healthcare privacy teams do first when COVID-19 patient volumes surge and access risk rises?

Start with a maintained list of COVID-19 positive patients and make privacy teams responsible for it. A single, current reference point lets analysts focus monitoring on the right records, reduces manual effort, and supports faster review when access spikes. The list becomes the intake layer for a patient privacy monitoring program and helps teams spot inappropriate access before concerns turn into broader privacy incidents.

What privacy teams need first when patient volumes spike

The first move is to create and maintain a current list of COVID-19 positive patients, then assign privacy ownership for that list. That gives the team one reliable intake layer for monitoring, reduces ad hoc searching, and lets reviewers focus on the records most likely to attract inappropriate access during a surge.

The key operational point is that privacy monitoring becomes much harder when the population of interest is inferred from scattered encounters, notes, or alerts. A maintained list turns a broad volume problem into a defined review queue, which is what makes timely oversight feasible when access pressure increases.

Why the maintained list changes the monitoring model

A maintained list is not just a data artifact. It is the control point that aligns the privacy workflow with the actual risk population, so the team can compare who accessed the chart, when access occurred, and whether that access made sense for treatment, operations, or other permitted purposes. Without that reference point, teams spend time hunting for the right records instead of reviewing suspicious access patterns.

This also improves consistency. If the list is current and ownership is clear, privacy analysts can apply the same review logic across all positive patients instead of relying on different units or managers to flag concerns. That matters during a surge because the volume increase usually stresses manual review first, not policy language.

For teams operating under broader privacy and data-protection obligations, the same discipline supports EU General Data Protection Regulation (GDPR) principles around data protection by design and security of processing, and it fits the organisational privacy-risk focus of the NIST Privacy Framework.

How to operationalise the first response without overcomplicating it

The practical sequence is simple: identify the positive-patient population, maintain the list continuously, and route it to the privacy function as the intake source for monitoring. After that, the team can prioritise unusual access, repeated access without a clear job need, and access to records that sit outside the reviewer’s expected care domain.

What to verify is whether the list is timely enough to reflect the current patient population, whether exclusions are documented, and whether the privacy team can act on the list without waiting for another department to repackage the data. If the list lags the clinical reality, the monitoring program will always be reacting late.

For teams that need a control baseline, the expectation maps well to access-control and audit practices in NIST SP 800-53 Rev 5 Security and Privacy Controls, and to the operational safeguard set in CIS Controls v8 around account management, access control, and audit logging.

Risk and Threat Considerations

When COVID-19 volumes surge, the main risk is not just heavier workload, it is missed inappropriate access because reviewers cannot keep pace with the number of charts that need attention. The absence of a maintained reference list turns privacy review into a search problem, and that delay increases the chance that a questionable access event is noticed only after it has already become a reportable privacy issue.

Failure mechanism: The surge creates more records, more viewers, and more noise, while the privacy team lacks a single maintained intake list to focus monitoring on the correct patient set. That weakens detection, slows triage, and makes it easier for inappropriate access to blend into routine workflow access.

Impact: Privacy teams can miss early warning signs, allow repeat access to continue unchecked, and lose the ability to show that monitoring was timely and targeted. In a healthcare environment, that can translate into broader privacy incidents, slower containment, and more difficult post-incident review.

That monitoring burden is one reason access review should be tied to a defined patient population rather than left to general chart surveillance, and why teams often anchor their incident-response posture to operational guidance such as NCSC UK Advice and Guidance for remote-access and monitoring discipline.

Standards & Framework Alignment

This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.

NIST SP 800-53 Rev 5 and CIS Controls v8 set the technical controls, while ISO/IEC 27001:2022 and GDPR define the regulatory obligations.

Framework	Control / Reference	Relevance
NIST SP 800-53 Rev 5	AU-6 — Audit Review, Analysis, and Reporting	Surge monitoring depends on timely review of access events for a defined patient set.
	AC-6 — Least Privilege	The question is about limiting and spotting unnecessary access as volumes rise.
Recommendation — Prioritise access log review for the maintained positive-patient population. Limit chart access to the minimum needed for care and operations.
ISO/IEC 27001:2022	A.5.15 — Access control	The answer centers on controlling who can access a sensitive patient population.
Recommendation — Define and enforce access rules for the monitored patient list.
CIS Controls v8	CIS-8 — Audit Log Management	Privacy teams need reliable audit visibility to spot inappropriate access during spikes.
Recommendation — Collect and review access logs for the positive-patient cohort.
GDPR	Article 32 — Security of processing	The control supports secure handling and oversight of sensitive patient data.
Recommendation — Use targeted monitoring to protect sensitive health records.

Practitioner Guidance

What to prioritise: Build the maintained positive-patient list first, then assign explicit privacy ownership before you expand the review logic. If the intake source is not dependable, everything downstream becomes slower and less defensible.

What to verify: Confirm the list is current enough for same-day or near-real-time review, and that the privacy team can see the fields needed to judge access legitimacy without extra manual reconciliation. If the team still needs to chase other departments for the patient set, the control is not ready.

Practitioner takeaway: The right first move is to make monitoring easier before trying to make it smarter, because a current owned list gives privacy teams the clearest path to fast, targeted review when surge conditions raise access risk.